• Compartir
  • Enviar por correo
  • Insertar
  • Me gusta
  • Guardar
  • Contenido privado



  • 1,445 reproducciones




reproducciones totales
reproducciones en SlideShare
reproducciones incrustadas


Me gusta

0 insertados 0

No embeds



Detalles de carga

Uploaded via as Adobe PDF

Derechos de uso

© Todos los derechos reservados

Report content

Marcada como inapropiada Marcar como inapropiada
Marcar como inapropiada

Seleccione la razón para marcar esta presentación como inapropiada.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Tu mensaje aparecerá aquí
Publicar comentario
Edite su comentario

    Bibliografia Bibliografia Document Transcript

    • BIBLIOGRAFÍA. BIBLIOGRAFÍA Craig J, Currie BSC, y cols. The Epidemiology and cost of CAPITULO I Inpatient Care for Peripheral Vascular Disease, Infection, Admson U, Larsson Y, _stman J. On the Saint Vincent Neuropathy and Ulceration in Diabetes. Diabetes declaration. In Swedish. (Konsensus i Europa-allm@nna Care,1998; 21: 42-52. mDl och femDrsprogram: Saint Vincent-deklarationen Currie CJ, Morgan CLl, Peters JR. The epidemilogy and f`r b@ttre diabetesv@rd). L@kartidningen 1991; 88 (28- costs of inpatient care for peripheral vascular disease, 9): 2464-5. infection, neuropathy, and ulceration in diabetes. American Diabetes Association. Standard of Medical Care Diabetes Care 1998; 21: 42-46. for Patients with diabetes Mellitus. Position statements. Department of Health and Human Services: Healthy Diabetes Care 1998; 21: s23-s31. people 2000: National health promotion and disease Apelqvist J, Ragnarson-Tennvall G y cols. Diabetic foot prevention objectives. (DHHS publication no. 91-50213) ulcers in a multidisciplinary seting. An economic analysis Washington, DC, Government Printing Office, 1991, pp of primari healing and healing with amputation. J Inern 73-117. Med 1994; 235: 463- 471 Diabetes Control and Complications Trial (DCCT). The Apelqvist J, Ragnarson-Tennvall G y cols. Long-term costs effect of intensive treatment on the developmet and for foot ulcers in diabetic patients in a multidisciplinary progression of long-term complications in insulin depen- setting. Foot Ankl Int 1995; 16: 388-394 dent diabetes Mellitus. N Eng J Med. 329: 986-990, 1993. Bouter KP, Storm AJ y cols. The diabetic foot in Dutch Dorman J.S., Laport R.E., Kuller L.H., y cols. The Pittsburgh hospitals: epidemiological features and clinical outcome. insulin-dependent diabetes mellitus (IDDM). Morbility Eur J Med 1993; 2: 215-218 and mortality sudy diabetes. 1984.33: 271-276, 187 Butlletí Epidemiológic de Catalunya. Vol. XVIII, nº 3. Març Ernst CB, Rutkow IM, Cleveland RJ, et al. Vascular surgery 1997. in the United States. Report of the Joint Society for Vascular Surgery- International Society for Cardiovascular Canadian Diabetes Association. "Prevalence of diabetes". Surgery Committe on Vascular Surgical Manpower. J Feb 1996. Vasc Surg 1987; 6:611-21. Carrington A, Abbott C, y cols. Prevalence and preven- Esmatjes E, Castells C, y cols. The Catalan Diabetic tion of foot ulceration and amputation in North Western Nephropaty Study Group. Epidemiology of renal invol- England (Abstract). Diabetes 1996;45(suppl 2):26ª vement in Type II diabetics in Catalonia. Diabetes Res Centers for Disease Control and Prevention: Diabetes Clin Pract 1996; 32: 157-163 Surveillance. Atlanta, GA, U.S. Department of Health Fernandez-Vigo J, Macho JS, y cols. The prevalence of and Human Services, Public Health Service, 1991. diabetic retinopathy in Nortwest Spain. Acta Ophtalmol Challeton JP, Letanoux M. y cols. Le pied diabétique: 1993;71:22-26 pronostic dans une serie de 75 patients.Rev Med Interne Franch Nadal J, Alvarez Torices JC, Alvarez Guisasola F, 1993; 14:1036 Diego Dominguez F, Pablo Pons M, Hernández Mejía Chukwuma C,Tyre I. Diabetic nephropaty: clinical charac- R. El diagnóstico de la Diabetes Mellitus en los estudios teristics and economic impact. J Diabetes Complication epidemiológicos. Aten Primaria 1991 ; 8 : 33-38. 1993; 7: 15-27 Goday A, Serrano-Rios M. Epidemiologia de la diabetes Connor H. The economic impact of diabetic foot disease. mellitus en España. Revisión crítica y nuevas perspec- In: The foot in diabetes (eds. Connor H, Boulton AJM, tivas. Med Clin 1994; 102: 306-315. Ward JD). Wiley and Sons Ltd. New York 1987: 145-9 Humphrey LL, Ballard DJ, Butters PJ, Palumbo PJ, Craig J, Currie BSC, y cols. The Epidemiology and cost of Hallett JW. The epidemiology of lower extremity Inpatient Care for Peripheral Vascular Disease, Infection, amputation in diabetics: a population based study Neuropathy and Ulceration in Diabetes. Diabetes in Rochester, Minnesota (Abstrsct). Diabetes 1989; 2 Care,1998; 21: 42-52. (Suppl 2):33A.
    • TRATADO DE PIE DIABÉTICO Humphrey ARG, CHB-G.K. MB y cols. Diabetes and Nabarro JDN. Diabetes in the United Kingdom: some facts Nontraumatic Lower Extremity amputations. Diabetes and figures.Diabet Med 1988; 5:816-822. Care 1996; 19:710 Nelson RG, et al. Lower-extremity amputations in Humphrey LL, Palumbo PJ y cols. The contribution on NIDDM:12-yr follow-up study in Prima Indians. Diabetes non insulin dependent diabetes to lower.extremity Care 1988; 11:8-16. amputation in the community. Arch Intern Med 1994; NIH Publication nº 96-3926. October de 1995 154: 885-892. Olympia, WA, State Department of Health, Diabetes Ibáñez Esquembre, V. Estudio de prevalencia de pato- Control Program, 1991. Lower extremity amputations logía vascular en una población con DMNID. Tesis among people with diabetes, Washington state, 1985- Doctoral; Granada 1991. 88. Javitt JC, Aiello LP,Bassi LJ, et al. Detecting and treating Ordenación de recursos para la atención sanitaria de las retinopathy in patients with type 1 diabetes mellitus. personas con diabetes. MSC, Feb 1996. Ophtalmology 1991; 98:1565-1573 Preston SD, Rieber GE, Koepsell. Lower extremity ampu- Krans, H.M., Porta, M., Kee, H., Diabetes Care and tations and inpatient mortality in hospitalized persons Research in Europe: The Saint Vincent Declaration Action Programme. Implementation Document. Giornale with diabetes: national population risk factors and asso- Italiano di Diabetologia, 1992; 12. ciations. University of Washington Thesis 1993. Laing W, Williams R. Diabetes: a model for health care Ratzman KP, Drzimalla E, Raskovic M. The diabetic management. London: Office of Health Economics,1989. foot sindrome. Association with other complications and the incidence of amputation. Med Klin 1994; 89: Laing P, Cogley D, Klenerman L. Economic aspects of the 469-472 diabetic foot. Foot 1991; 1:111-2. Reiber GE. Epidemiology of the diabetic foot. In: Levin Melton L, Macken K, y cols. Incidenece and prevalence ME, O=Neal LW, Bowker JH (eds). The Diabetic Foot, of clinical peripheral vascular disease in a population- 5th edn. St Louis: Mosby Year Book 1993; 1-15. 188 based cohort of diabetic patients. Diabetes Care 1980;3:650-654. Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995 p. 408-28 (DHHS publ. no. 95-1468). Ministerio de Sanidad y Consumo. Consenso para la Atención a las personas con Diabetes en España. Centro Reiber GE. The epidemiology of diabetic foot problems. de Publicaciones del Ministerio de sanidad. Madrid, 1995 Diabet Med 1996; 13: 6-11 Ministerio de sanidad y Consumo. Ordenación de recursos Seppo Lehto, MD_Tapani Ronnemaa, y cols. Risk factors para la Atención sanitaria de las personas con diabetes. predicting lower extremity amputations in patients with Panel de Expertos Aten Primaria, 1996: 17; 471-479. NIDDM. Diabetes Care 1996; 19: 607. Mundet X, Cano J, Mata M. y cols. Diabetic chronic compli- Tero Kangas MD, PhD-Seppo Aro y cols. Structure and cations in type 2 diabetes: a multicentric study. costs of health care of diabetic patients in Finland. Diabetologia 1997; 40 (suppl 1): A 203 Diabetes Care 1996; 19: 494-497
    • BIBLIOGRAFÍA. Greene DA, Lattimer SA, Sima AAF. Pathophysiology CAPITULO II of diabetic neuropathy. In Ellember and Rifkin’s Alberti KGMM, Zimmet PZ. Definition, diagnosis and clas- Diabetes Mellitus. Eds. Rifkina dn Porte. Elsevier. sification of diabetes mellitus and its complications. Part 1990 1: diagnosis and classification of diabetes mellitus provi- Kjolseth D, Frank JM, Barker JM et al. Comparison of the sional report of a WHO consultation. Diabetic Med 1998; effects of commonly used wound agents on epithe- 15: 539-553. lialization and neovascularization. Am. Coll. Surg, 1994, Alberti KGMM, De Fronzo RA, Keen H, Zimmet Eds. 179:305-12. International. textbook of diabetes mellitus.J. Willey Klein R, Klein B. Vision disorders in diabetes. In: Diabetes and Sons. Chichester. 1992. Vol 2, p 1729. in America, NDDG,NIH Publication, 1995:293-338. American Diabetes Association. Report of the Committee Klein R, Klein B, Moss s. Y cols. The Wisconsin on the diagnosis and Classificatios of Diabetes mellitus. Epidemiologic Study of diabetic Retinopa- Diabetes Care 1997; 20: 1183-1197. thy.II.Prevalence and risk of diabetic rertinopathy Archer AG, Robert VC, Watkins PJ: Blood Flow patterns in when age at diagnosis in less than 30 years. Arch painful diabetic neuropathy. Diabetología 27:563, 1984. Ophtalmol 1984;102:420-526. Boulton A., Hardisty C., Betts R., et al. Dynamic foot pres- Leutenegger M,Pasqual C: Les lésions des pieds chez les sure and other studies as diagnostic and management diabétiques .In: Traité de diabétologie, Ed.Pradel, Paris aids in diabetic neuropathy. Diabetes care 6: 26, 1983. 1990,pags.581-587 Brand PW. The diabetic foot. In: Ellenberg M, Rifkin H Marinel.lo J, Blanes JI, Escudero JR, Ibáñez V, Rodriguez (eds). Diabetes mellitus: theory and practice. 3rd rev. Olay J. Consenso Sobre Pié Diabético. Angiología 1997; ed. New Hyde Park. N Y: Medical Examination Publishing 5: 193-230 Co. 1983: 829-49. Relimpio F, Pumar A, Losada F, y cols. Urinary albumin BrowerA.C.,AllmanR.M. Pathogenesis of the neuroth- excretion rate and cardiovascular disease in Spaniard ropic joint: Neurotraumatic vs. Neurovascular. Radiology type 2 diabetic patients. Diabetes Res Clin Pract 189 1981. 139: 349-354, 1997;36:127-134 Carella MJ, Gossain W, Rovner DR. Early Diabetes Rewers M, y cols. Prevalence of coronary heart in subjets Nephropathy. Arch Ontern Med 1994; 154 : 625-630 with normal and impaired glucose tolerance and non- De Fronzo RA, Reasner C: The diabetes control and compli- insulin-dependent diabetes mellitus in a biethnic cations Trial Study: implications for the diabetic foot. J Colorado population. Am J Epidemiol 1992; 135: 1321- Foot Ankle Surg 1994, Nov-Dec; 33(6): 551-6 1330 Deckert T, Pulsen JE, Larsen M. Prognosis of diabetics Stiegler H, Standl e, Schulz K, y cols. Morbidity, morata- with diabetes onset before the age of thity-one: survival, lity, and albuminuria in Type 2 diabetic patients: a three- causes of deaht, and complications. Diabetología 1978; year prospective study of a random cohort in general 14: 363-370 practice. Diabetic Med 1992;9: 550-556. Diabetes Drafting Group. The World Health Organization UK Prospective Diabetes Study Group. Effect of intensive Multinational Study of Vascular Dosease in Diabetics. blood glucose control policy with metformin on compli- Prevalence of small vessel and large vessel disease in cations in type 2 diabetes patients (UKPDS 34). Lancet diabetics patients from 14 centres. Daibetología 1985: 1998; 352: 854-865. 28:615-640. UK Prospective Diabetes Study. UKPDS 30. Diabetic reti- Frock JL and Joseph WS. Bone and soft tissue infections nopathy at diagnosis of non-insulin-dependent diabetes of the lower extremity in diabetics. Clinics in Paediatric mellitus and associated risk factors. Arch Ophtalmol Med and Surg; 1995, 12(1): 87-103. 1998; 116: 297-303.
    • TRATADO DE PIE DIABÉTICO hospitalaria. Relación con las demás complicaciones CAPITULO III diabéticas. Avances en Diabetología 1995;10:11-18 Apelqvist J, Larsson J,Agardh CD. Long-term prognosis Grayson ML, Gibbons GW, Balogh K y cols. Probing to bone for diabetic patients with foot ulcers. J Intern Med 1993; in infected pedal ulcers. A clinical sing of underlying oste- 233: 485-491. omyelitis in diabetic patients. JAMA 1995; 273: 721-23 Armstrong DG, Lavery LA,. Diabetic foot ulcers: preven- Hathan DM. Long-term complications of diabetes mellitus. tion, diagnosis and classification. Am Fam Phys 1998; N Engl J Med 1993; 328: 1676-1685 March 15: 1325-1336. Kohn O, Wagner W, Bessman AN. Mortality of diabetic Boulton, AJM, Betts, RP, Franks Ci, Ward, JD and Duck patients treated surgically for lower limb infection and/or worth, T: the natural history of foot pressure abnor- gangrene. Diabetes 1974; 23:287 malities in neuropathic diabetic subjects. Diabetes Res., 5: 73-77,1987. Levin ME, O'Neal LW. Preface. In: Levin ME, O'Neal LW, eds. The Diabetic Foot. St Louis: CV Mosby. 1988: ix-x. Boulton AJM, Betts RP, Franks CI et al. Abnormalities of foot pressure in early diabetic neuropathy. Diabet Med Levin ME. Diabetic foot ulcers: pathogenesis and mana- 1987; 4:225-8. gement. J ET Nurs 1993; 20 : 191-198. Boulton, A.J., Betts, R.P., Franks C.I., Ward, J.D., and Duck- Levin ME, O’Neal LW, Bowker JH eds. The diabetic foot worth,T.: The natural history of foot pressure abnor- 5th ed. St. Louis . Mosby . 1993. malities in neuropathic diabetic subjects. Diabetes Lumley JS. Vascular management of the diabetic foot a Res.,5:73-77,1987. British view. Ann Acad Med Singapor 1993; 22: 912-916 Boulton, A.J.M. The Diabetic Foot. Medical Clinics of MacLeod AF, Williams DRR, Sonksen PH, Boulton AJM. North America. 1988 Vol. 72 nº 6. Risk factors for foot ulceration in hospital clinic atten- Boulton AJM, Connor H, Cavanagh PR eds. The foot in ders (Abstract). Diabetologia 1991; 34 (Suppl 2):A39. diabetes. 2nd ed. Chichester, England. John Wiley & Marguerite J,Mcneely y cols. The independent contribu- 190 sons ltd. 1995. tions of diabetic neuropathy and vasculopathy in foot Boulton AJM. The patogenesis of diabetic foot problems: ulceration. How great are the risks ?. Diabetes Care an overview. Diabet Med 1996; 13:S12-S16. 1995; 18: 216-219 Cavanagh,P.R.,Simoneau,G.G.,and Ulbrecht,J.S.: Ulcer- Orchard T, Olson J, y cols. Predictors of subclinical athe- ation, unsteadiness and uncertainty: the biomechanical rosclerosis in IDDM subjects (Abstract) In: International conse-quences of diabetes mellitus. J.Biomech., 26(1):23- Diabetes Epidemiology Group Symposium, Savolinna, 40,1993. Finland, 1997: 0022. De Fronzo RA, Reasner C: The diabetes control and compli- Palumbo PJ, Melton LJ. Peripheral vascular disease and cations Trial Study: implications for the diabetic foot. J diabetes. In: Harris MI, Hamman RF eds. Diabetes in Foot Ankle Surg 1994, Nov-Dec; 33(6): 551-6 America. NIH Pub. No. 85-1468. Washington: US Governement Printing Office, 1985:XV 1-21. Frykberg RG. Diabetic foot ulcerations. En: The High Risk Foot in Diabetes Mellitus, Frykberg RG ed. NY, Churchill Scher KS and Steele FJ. The septic foot in patients with Livingstone, 1991, pp:151-195. diabetes. Surgery; 1988, 104:661-665. Goicolea I, Mancha A, y cols. Prevalencia de microal- Shaw JE, Boulton AJ. The pathogenesis of diabetic foot buminuria y proteinuria en una población diabética problems: an overview. Diabetes 1997; 46: 58-61
    • BIBLIOGRAFÍA. Laverly LA, Armstrong DG, Harkless LB. Classification CAPITULO IV of diabetic foot wounds. Ostomy Wound Manage Brodsky J.W. The diabetic and insensitive foot. J. Orthop. 1997; 43: 44-48 Surg1989. 3:1, Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Brodsky J.W. Outpatient diagnosis and care of the diabetic Fleischli JG. Practical criteria for screening patients foot. Instructional Course Lectures 1993.42: 121-131, at high risk for diabetic foot ulceration. Arch Inte Med 1998; 158: 157-162. Dyck PJ, Stiller R. Signpost to the detection of diabetic peripheral neuropathy. Wyeth-Ayerst, 1990 Ramsey DE, Manke DA, Sumner DS. Toe blood pres- sure: a variable adjunct to ankle pressure measu- European Working Group on Critical Leg Ischaemia . rement for assessing peripheral arterial disease. J Second European Consensus Document on Chronic Cardiovasc Surg 1983; 24:43. Critical Leg Ischaemia. Circulation 1991; 84 (suppl.4): 1. Strandness DE,Priest RE, Gibbons GE.Combined clinical European Working Group on Critical Limb Ischaemia. and pathologic study of diabetic and no diabetic Secons European Consensus Document on Chronic peripheral arterial disease.Diabetes 1964;13:366-372 Critical Leg Ischaemia. Eur J vasc Surg 1992; 6 suppl A: Sapico FL, Canawati HN, Witte JL et al. Quantitative 1-32 aerobic and anaerobic bacteriology of infected Gooding G.A.W., Stess R.A., Graft P.M., et al. Sonography diabetic feed. J. Clin. Microbiol; 1980, 12:413-420. of the sole of the foot: Evidence of loss of foot pad Second European Consensus Document on Chronic thickness in diabetes and its relationship to ulceration Critical Leg Ischaemia. Chronic Critical Leg Ischaemia. of the foot. Invest. Radiol. 1986.21: 45, Eur J Vasc Surg 1992; 6 (Supplement A), pag. 15. Greene DA, Lattimer SA, Sima AAF. Pathogenesis and The Diabetes Control and complications Trial Research prevention of diabetic neuropathy. Diabetes Metab Rev. Group. The effect of intensive diabetes therapy on 4, 201.221. 1988. the development and progression of neuropathy. Harrelson J.M. The diabetic foot: Charcot arthropaty. Annals of Int Medic 1995; 122: 561-568 191 Instructional Course Lectures.1993 XXXXII: 141-146,. Young MJ, Boulton AMJ y cols. A Multicentric study of the prevalence pf diabetic peripheral neuropathy in the Kumar S, Ashe HA, y cols. The prevalence of foot ulce- UK Hospital Clinic Population. Diabetología,1994 ration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994; 11: 480- Wagner F.W. Jr. The dysvascular foot: A system for 484 diagnosis and treatment. Foot Ankle 1981. 2: 64-122,
    • TRATADO DE PIE DIABÉTICO Huntley AC. The cutaneous manifestations of Diabetes CAPITULO V Mellitus. J Am Acad Dermatol 1982;7:427-458. Akimoto S, Ishikawa O, Miyachi Y. Plantar thrombotic Pujol RM, Moragas JM. Manifestaciones cutáneas de la nodules with marked neovascularization in diabetes: a diabetes mellitus. JANO 1991; 40:47-54. symptom which has been overlooked? J Dermatol 1997; 24: 405-409. Riambau V. Lesiones tróficas cutáneas asociadas al pie D.W. Beaven, S.E. Brooks. Las uñas en el diagnóstico diabético. Actualidad Dermatológica 1993; 32:185- clínico. Ed. Espaxs. Barcelona 1985. 197 Fitzpatrick, Johnson, Polano et al. Atlas de Dermatología Sibbald RG, Schachter RK. The skin and Diabetes Mellitus. Clínica. Ed. Interamericana. Mexico 1994. Int J Dermatol 1984;23:567-584. 192
    • BIBLIOGRAFÍA. Golbranson FL, Yu EC, Gelberman RH. The use of skin CAPITULO VI temperature determinations in lower extremity ampu- Adera HM, James K, Castronuovo JJ, et al. Prediction of tation level selection. Foot Ankle 1982; 3:170-2. amputation wound healing with skin perfusion pres- Hauser CJ, Shoemaker WC. Use of a transcutaneous Po2 sure. J Vasc Surg 1995; 21:823-9. regional perfusion index to quantify tissue perfusion Bacharach JM, Rooke TW, Osmundson PJ, Gloviczki P. in peripheral vascular disease. Ann Surg 1983; 197:337. Predictive value of transcutaneous oxygen pressure and Harward RS, Volny J, Golbranson F, Bernstein EF. Oxygen amputation success by use of supine and levation measu- inhalation-induced transcutaneous Po2 changes as a rements. J Vasc Surg 1992; 15:558. predictor of amputation level. J Vasc Surg 1985; 2:220- Barnes RW, Shanik GD, Slaymaker EE. An index of healing 7. in below-knee amputation: leg blood pressure by Holloway GA Jr. Cutaneous blood flow responses to injec- Doppler ultrasound. Surgery 1976; 79:13. tion trauma measured by laser Doppler velocimetry. J Bone GE, Pomajzl MJ. Toe blood pressure by photo- Invest Dermatol 1980; 74:1. plethysmography: an index of healing in forefoot ampu- Holloway GA Jr, Burgess EM. Preliminary experiences with tation. Surgery 1981; 89:569-74. laser Doppler velocimetry or the determinationof ampu- Bongard FS, Upton RA, Elings VB et al. Digital cutaneous tation levels. Prosthet Orthot Int 1983; 7:63. fluorometry: correlation between blood flow and fluo- Holstein P. Distal blood pressure as a guide in choice of rescence. J Vasc Surg 1984; 1:635. amputation level. Scand J Clin Lab Invest 1973; 31 (Suppl Borozan PG, Schuler JJ, Flanigan DP. The accuracy of 128):245. segmental Doppler pressures in predicting healing of Holstein P, Lund P, Larsen B, Schomacker T. Skin perfu- below-knee amputation in diabetic patients. sion pressure measured as the external pressure required Unpublished data presented at the Association of VA to stop isotope wash-out. Methodological considera- Surgeons Meeting, Los Angeles, California, May 9-12, tions and normal values on the legs. Scand J Clin Lab 1984. Invest 1977; 30:649. 193 Boulton AJM, Kubrusly DB, Browker JH, et al: Impaired Holstein P, Lassen NA. Assessment of safe level of ampu- vibratory preception and diabetic ulceratión. Diabetic tation by measurement of skin blood pressure. In Med. 3: 335, 1986. Rutherford RB (ed): Vascular Surgery. Philadelphia, WB Bhurnham ST, Wagner WH, Keagy BH, Johnson G Jr. Saunders Co 1977; 105-11. Objective measurement of limb perfusion by dermal Holstein P, Sager P, Lassen NA. Wound healing in below fluorometry. A criterion for healing of below knee knee amputations in relation to skin perfusion pres- amputation. Arch Surg 1990; 125:104- sure. Acta Orthop Scand 1979; 40:49. Cederberg PA, Pritchard DJ, Joyce JW. Doppler-deter- Holstein P. Level selection in leg amputation for arterial mined segmental pressures and wound-healing in ampu- occlusive disease: a comparison of clinical evaluation tations for vascular disease. J Bone Joint Surg (Am) 1983; and skin perfusion pressure. Acta Orthop Scand 1982; 65 A: 363-5. 53:821. Durham JR. Lower extremity amputation levels: indica- Holstein P, Trap-Jensen J, Bagger H, Larsen B. Skin perfu- tions methods of determining appropiate level, tech- sion pressure measured by isotope washout in legs with nique, prognosis. In Rutherford RB (ed): Vascular Surgery. arterial occlusive disease. Clin Physiol 1983; 3:313. Philadelphia, Saunders 1989; 764. Holstein P. The distal blood pressure predicts healing of Faris I, Duncan H. Skin perfusion pressure in the predic- amputations on the feet. Acta Orthop Scand 1984; tion of healing in diabetic patients with ulcers or 55:227. gangrene of the foot. J Vasc Surg 1985; 2:536-40. Holstein P. Skin perfusion pressure measured by radioi- Franzeck UK, Talke P, Bernstein EF, et al. Transcutaneous sotope washout for predicting wound healing in lower pO2 measurements in health and peripheral arterial limb amputation for arterial occlusive disease. Acta occlusive disease. Surgery 1982; 91:156-63. Orthop Scand 1985; 56(Suppl):213. Gibbons GW, Wheelock Jr FC, Siembieda C, Hoar Jr CS, Karanfilian RG, Lynch TG, Zirul VT, et al. The value of et al. Noninvasive prediction of amputation level in Laser Doppler velocimetry and transcutaneous oxygen diabetic patients. Arch Surg 1979; 114:1253-7. tension determination in predicting healing of ischemic
    • TRATADO DE PIE DIABÉTICO forefoot ulcerations and amputations in diabetic and Nicholas GG, Myers JL, DeMuth WE. The role of vascular nondiabetic patients. J Vasc Surg 1986; 4:511-6. laboratory criteria in the selection of patients for lower extremity amputation. Ann Surg 1982; 195:469-73. Katsamouris A, Brewster DC, Megerman J, et al. Transcutaneous oxygen tension in selection of ampu- Pollack SB, Ernst CB. Use of Doppler pressure measu- tation level. Am J Surg 1984; 147:510-7. rements in predicting success in amputation of the leg. Am J Surg 1980; 139:303. Kram HB, Appel PL, Shoemaker WC. Multisensor trans- cutaneous oximetric mapping to predict below-knee Ratliff DA, Clyne CAC, Chant ADB, Webster JHH. Prediction amputation wound healing: use of a critical Po2. J Vasc of amputation wound healing: the role of transcuta- Surg 1989; 9:796-800. neous pO2 assessment. Br J Surg 1984; 71:219-22. Kohler TR, Nance DR., Cramer MM. Duplex scanning for Schwartz JA, Schuler JJ, O?Connor RJA et al. Predictive diagnosis of aortoiliac and femoropopliteal disease: A value of distal perfusion pressure in the healing of prospective study. Circulation. 1987; 6: 460-9. amputations of the digit and the forefoot. Surg Gynecol Obstet 1982; 154:865 Langsfeld M, Nepute J, Hershey FA, Thorpe L, Auer AI, Binnington HG, Hurley JJ, Peterson GJ, Schwartz R, Stockel M, Ovensen J, Brochner-Mortensen J et al. Woods JJ. The use of deep dupplex scanning to predict Standardized photoelectric technique hemodynamically significant aortoiliac stenoses. J Vasc as routine method for selection of amputation level. Acta Surg. 1988; 7: 395-9. Orthop Scand 1982; 53:875. Legemate DA, Teeuwen C, Hoenveld H, Eikelboom BC. Stoner HB, Taylor L, Marcuson RW. The value of skin How can the assessment of the hemodynamic signifi- temperature measurements in forecasting the healing cance of aortoiliac stenoses. J Vasc Surg. 1993; 17: 676- of below-knee amputation for end stage ischemia of 84.Lelièvre. Patología del pie. Ed. Toray-Masson, the leg in peripheral vascular disease. Eur J Vasc Surg Barcelona (1976). 1989; 3:355-61. Moneta GL, Yeager RA, Antonovic R, Hall LD, Caster JD, 194 Stradness Jr DE: Peripheral arterrial system, in Stradness Cumming CA, Porter JM. Accuracy of lower extremity Jr DE (de): Duplex Scanning in Vascular Disorders, New arterial dupplex mapping. J Vasc Surg. 1992; 15: 275- York, NY, Raven Press, 1993, pp 159-95. 84. Wyss CR, Harrington RM; Burgess EM, Matsen FA. Moneta GL, Yeager RA, Taylor LM, Porter JM. Transcutaneos oxygen tension as a predictor of success after Hemodynamic Assessment of combinaed aortoiliac/femo- an amputation. J Bone Joint Surg (Am) 1988; 70:203-7. ropopliteal occlusive disease and selection of single or multilevel revascularization. Semin Vasc Surg. 1994; 7: Yao ST. Choice of amputation level. J Vasc Surg 1988; 3-10. 8:544-5.
    • BIBLIOGRAFÍA. JS and Swartz MW) Current Clinical Topics in Infectious CAPITULO VII Diseases. Boston, Blackwell Scientific Publications. 1994 Antiplatelet Triallista Collaboration. Secondary preven- (14): 1-22. tion of vascular disease by prolonged antiplatelet treat- McIntyre KE: Controle of infection in the diabetic foot: ment. Br. Med 1988, 296:320-331. the role of microbiology, inmunophathology, antibiotics. Caprie. Steering Committee. A randomized, blinded, trial J Vasc Surg 1987; 5: 787-790 of clopidogrel vs aspirin in patients at risk of ischaemic Mulder GD. Tepelidis N. The Diabetic Foot: Medical events. Lancet 1996. 348: 1329-1339 Management of foot ulcers. Clinical Material 1991, Cloarec et al. Double-blind clinical trial of Ticlopidine vs 8:273-7. placebo in peripheral atherosclerotic disease of the legs. Rogatti W. Prostaglandin E, in atherosclerosis. Springer Trmob Res 1986 (suppl. 6): 160. Verlag, Berlin 1986: 92-98. Coffman, J.D. Intermittent Claudication: be conserva- Norgren L. et al. A stable prostacyclins analogue in the tive. N. Engl. J. Med. 1991; 325:577-8. treatment of ischaemic ulcers of the lower limb a Dickhaut SC, Delee JC, Page CP. Nutritional status: impor- Scandinavian –Polish placebo-controlled,. Randomised tance in predicting wound healing after amputation. J multicenter study. Eur J Vasc Surg 1990;4: 453-467 Bone Joint Surg (Am) 1984; 66:71-5. Shakir et al. Decreased phospholipase A2 activity in plasma Eckman MH, Greenfield S, Mackey WC et al. Foot infec- and liver in uncontrolled diabetes mellitus. A defect in tions in diabetic patients: decision and cost-effective the early steps of prostaglandin synthesis?. Diabetes analyses. JAMA 1995; 273:712-20. 1986,35:403-410. Edmonds ME. Management of the diabetic foot. Crit Stiegler H, Diehm C, Grom E et al. Estudio a doble ciego Ischaemia 1990; 1: 5-13 controlado con placebo de la eficacia de la prosta- Erlich KS, Rumack JS. Evaluation and management of glandina E1 en pacientes diabéticos con AOP en estadío nonhealing infected wounds in diabetics. Infect Med IV. Vasa 1992, 35:164-6. 1993; 10: 21-27. 195 Straus A, et al. Double-blind crossover syudy of the clinical Gómez J. Las infecciones del pie del diabético: un nuevo efficacy and the hemorheological effects of pentoxify- enfoque terapéutico. Rev. Esp. Quimioter; 1994, 7(3): lline in patient with occlusive arterial disease of the 191-194. lower limbs. Angiology 1984, 35: 459 Gruss, J. D., Vargas-Montano H, Bartels D. et al. Use of UK Prospective Diabetes Study Group. Intensive blood prostaglandins in arterial occlusive diseases. Inter Angio glucose control with sulphonylureas or insulin compared 1984 (Suppl.3) 7-17. with conventional treatment and risk of complications Heidrich et al. Longterm intravenous infusión of PGE1 in patients with type 2 diabetes (UKPDS 33). Lancet in peripheral arterial blood flow disorders. Results of 1998; 352: 837-853. an Open Screening Study with patients in Fontaine´s Walters D, Gatling W, y cols. The prevalence, detection, stages III and IV. In: Sinzinger, H; Rogatti W. and epidemiological correlates of pripheral vascular Prostaglandin E, in atherosclerosis. Springer Verlag, disease: a comparison of diabetic and non diabetic Berlin 1986: 92-98. subjects in a English community. Diabetic Med Hess H, Mietaschk A, Bruckl R. Peripheral arterial occlu- 1992;9:710-715. sions. A 6-year experience with local low-dose throm- Weaver FA, Toms C. The practical implications of recent bolytic therapy. Radiology 1987; 163:753-8. trials comparing thrombolytic therapy with surgery for Karchmer AW and Gibbons GW. Foot infections in lower extremity ischemia. Seminars in Vascular Surgery diabetes: evaluation and management. En: (Remington 1997; 10:49-
    • TRATADO DE PIE DIABÉTICO Capek P, Mc Lean GK, Berkowitz HD. Femoropopliteal CAPITULO VIII angioplasty. Factors influencing long-term success. Abbot WM. Vignati JJ. Prostetic graft: When are they Circulation 1991; 83(suppl. l): l-70-l-80. reasonable alternative?. Semin Vasc Surg. 1995; 8: 236- Colapinto RF, Harris-Jones EP, Johnston KW. Percutaneus 45 transluminal dilatation and ecanalization in the treat- Abbot WM. Prosthetic above-knee femoral popliteal by ment of peripheral vascular disease. Radiology 1980; pass: Indications and choice of graft. Sem Vasc Surg 135:583-7. 1997; 10: 3-7. Criado E, Burham SJ, Tinsley EA, Johnson G, Keagy BA. Ahn SS, Obrand DI, Moore WS. Transluminal ballon angio- Femorofemoral bypass graft: Analysis of patency and plasty, stents and atherectomy. Seminars in Vascular factors influencing long term outcome. J Vasc Surg. Surgery 1997; 10:286-96. 1993; 18: 495-505. Bakal CW, Sprayregen S, Scheinbaum K, Cynamon J, Veith Criado E, Farber M. Femorofemoral bypass: appropiate FJ. Percutaneus transluminal angioplasty of the infra- applicatins based on factors affecting outcome. Sem vasc Surg 1997; 10: 34-41 popliteal arteries: results in 53 patients. Am J Roentgenol 1990; 154:171-4. Cronenwett JL, Lindenauer SM. Direct measurement of arteriovenuos anastomotic blood flow after lumbar Bakal CW, Cynamon J, Sprayregen S. Infrapopliteal percu- sympathectomy. Surgery 1977; 82:82-9. taneus Transluminal Angioplasty: what we know?. Radiology 1996; 200:36-43. Cronenwett JL, Zelenock GB, Whitehouse W jr., Stanley JC, Lindenauer SM. The effect of sympathetic innerva- Barth KH, Greenfield AJ, Grollman JH, Mitty HA, Van tion of canine muscle and skin blood flow. Arch surg Breda A. SCVIR position statement on thermal lasser 1983; 118:420-4. angioplasty. Radiology 1989; 172:944. Da Valle MJ, Bauemann FG, Mintzer R, Riles TS and Becker GJ, Katzen BT, Dake MD. Noncoronary Angioplasty. Imparato AM. Limited success of lumbar sympathec- Radiology 1989; 170:921-40. tomy in the prevention of ischemic limb loss in diabetic 196 Berkowitz HD, Greenstein SM. Improved patency in patients. Surg Gynecol Obstet 1981; 152:784-8. reversed femoral-infrapopliteal autogenous vein grafts Dalman RLTaylor LM, Moneta GL, Yeager RA, Porter JM. by early detection and treatment of the failing graft. Simultaneous operative repair of multilevel lower extre- J Vasc Surg 1987; 5:755-61. mity occlusive disease. J Vasc Surg. 1991; 13: 211-2 Berkowitz HD, Fox AD, Deaton DH. Reversed vein grafts Diaz Colodrero G, Altclas J, Jasovich A y cols. Microbiology stenosis. Early Diagnosis and management. J Vasc Surg and conservative surgery of serious infections of diab- 1992; 15:130-42. tetic foot. Enferm. Infecc Microbiol Clin 1992;10:451- Bernhard VM: Profundoplasty. In Rutherford R (ed): 455 Vascular Surgery 4th ed. Philadelphia, PA, Saunders, Dietzek AM, Gupta SK, Kram HB, et al. Lower loss with 1994, pp 828-34. patent infrainguinal bypasses. Eur J Vasc Surg 1990; 4 Bolia A, Bell PRF. Femoropopliteal and crural artery reca- 413. nalization using subintimal angioplasty. Seminars 1995; De Vries SO, HuninK MGM. Results of aortic bifurcation 8:253-64. grafts for aortoiliac occlusive disease: A meta-analysis. Brewster DC, Perler BA, Robison JG, Darling RC. J Vasc Surg. 1997; 26: 558-69. Aortofemoral graft for multilevel occlusive disease. Donaldson MC, Mannick JA, Whittemore AD. Femoral- Predictors of success and need for distal bypass. Arch distal bypass wiyh in situ saphenous vein: long term Surg. 1982; 117: 1593-600. results using the Mills valvulotome. Ann Surg. 1991; Burrell MJ, Wheeeler JR, Gregory RT. Axillofemoral bypass. 213: 457-69. A ten-years review. Ann Surg. 1982; 195: 796-9. Edwards JM, Taylor LM jr, Porter JM. Limb salvage in end- stage renal disease (ESRD): comparasion of modern Brewster DC, Cambria RP, Darling RC, Athanasoulis CA, results in patients without ESRD. Arch Surg 1988; Waltman AC, Geller SC, Moncure AC, Lamuraglia GM, 123:1164. Freehan M, Abbott WM. Long-term results of combined iliac ballon angioplasty and distal surgical revasculari- El-Massry S, Saad E, Sauvage LR, Zammit M, Davis CC, zation. Ann Surg 1989; 210:324-31 Smith JC, Rittenhouse EA, Fisher LD. Axillofemoral by-
    • BIBLIOGRAFÍA. pass with externally supported, Knitted Dacron grafts: Henry M, Amor M, Ethevenot G, Henry I, Amicabili C, A follow-up through twelve years. J Vasc Surg.1993; 17: Beron R, Mentre B, Allaoui M, Touchot N. Palmaz stent 107-15. lacement in iliac and femoro-popliteal arteries: primary and secondary patency in 310 patients with 2-4 year Fernandez Solares JI, Gutierrez JM, Llaneza JM, y cols. follow-up. Radiology 1995; 197:167-74. Angioplastia transluminal percutanea del sector femoro- popliteo en la isquemia crítica. Angiologia 1995; 5:257- Hewes RC, White RI, Murray RR, y cols. Long-term results 64. of superficial femoral artery angioplasty. Am J Roentgenol 1986; 146:1025-9. Franssetti et al. Epidural spinal electroestimulatory sistem in the management of diabetic foot and peripheral Horsch, S. Papel de la estimulación de la médula espinal arteriopathies. Pace 1989,12:705-708. en el tratamiento de la arteriopatía oclusiva periférica no reconstruible. Anales de Cir. Card. y Vasc. 1996 Vol Gerbarch P, Hasdemir MG, Stevens RD at al. Discriminative 2 Nº5: 192-8. Microcirculatory Screening of Patients with refractory Limb Ischaemia for dorsal colum stimulation. Eur J Vasc Horvath W, Oertl M, Haidinger D. Percutaneous translu- Endovasc Surg 1997. 13:464-471. minal angioplasty of crural arteries. Radiology 1990; 177:565-9. Gray BM, Sullivan TM, Childs MB, Young JR, Olin JW. High incidence of restenosis / reocclusion of stents in the Imparato AM. Simpatectomía lumbar. Papel en el trata- percutaneus tratment of long segment superficial miento de la enfermedad arterial oclusiva de las extre- femoral artery disease after suboptimal angioplasty. J midades inferiores. Clínicas Quirúrgicas de Norteamérica Vasc Surg 1997; 25:74-83. 1979; 4:717-32. Gray BM, Olin JW. Limitations of percutaneus translu- Jacobs MJHM, Jörning PJG, Beckers RCY et al. Foot Salvage minal angioplasty with stenting for femoropopliteal and improvement of microvascular blood flow as a result arterial occlusive disease. Seminars 1997; 10:8-16. of epidural spinal cord electrical stimulation. J. Vasc. Surg. 1990. 12:354-360. Greenhalgh RM; Jamieson CW, Nicolaides AN (eds). Limb salvage and amputation for vascular disease. W B Jivegard LEH, Augustinsson LE, Holm J et al. Effects of 197 Saunders Company, Philadelphia 1988 spinal cord stimulation in patients with inoperable lower limb ischaemia: a prospective randomised controlled Grover-Johnson N, Baumann FJ, Riles TS and Imparato study. Eur J Vasc Endovasc Surg. 1995,9:421-425. AM. Effects of surgical lumbar sympathectomy on inner- vation of arterioles in the lower limb of patients with Johnson G jr. Presidential address: The second genera- diabetes. Sur Gynecol Obstet 1981; 153:39-41. tion vascular surgeon. J Vasc Surg 1987; 5:211. Haimovici H, Steinman C. Aortoiliac angiographic patterns Johnston KW. Femoral and popliteal arteries: reanalisis associated with femoropopliteal occlusve dsease: of results of ballon angioplasty. Radiology 1992; 183:767- Significance in reconstructive arterial surgery. J 71. Cardiovasc Surg. 1969; 65: 232-40. Kadir S, Smith GW, White RI jr., Kaufman SL, Barth KH, Harrington ME, Schewartz ME, Samborn TA, Mitty H, Williams GM, O´Mara CS, Burdick JF. Percutaneus trans- Miller CA, Mc Ginnis K, Harrington EB. Expanded indi- luminal angioplasty as an adjunct to the surgical mana- cations for laser-assisted ballon angioplaty in peripheral gement of peripheral vascular disease. Ann Surg 1982; arterial disese. J Vasc Surg 1990; 11:146-55 195:786-95. Harrington ME, Harrington EB, Haimov M, Schanzer H, Kadir S, White RI jr., Kaufman SL, Barth KH, Williams GM, Jacobson II JH. Iliofemoral versus femoro-femoral bypass: Burdick JF, O`Mara CS, Smith GW, Stonesifer GL jr., Ernst The case for an individualized approach. J Vasc Surg. CB, Minken SL. Long-term results of aorto iliac angio- 1992; 16: 841-54. plasty. Surgery 1983; 94:10-4. Harris PL, How TV, Jones DR: Prospectively randomized Kalman PG, Hosang M, Cina C, Johnston KW, Ameli FM, clinical trial to compare in situ and reversed saphenous Walker PM, Provan JL. Current indications for axillou- vein grafts for femoropopliteal bypass. Br J Surg. 1987; nifemoral and axillobifemoral by-pass grafts. J Vasc 74: 252-5. Surg. 1987; 5: 828-32. Harris PL, Veith FJ, Shanik GD y cols. Prospective rando- Kalman PG, Johnston KW, Walker PM: The current role mized comparasion of in situ and reversed infrapopli- of isolated profundoplasty. J Cardiovasc Surg. 1990; 31: teal vein grafts. Br J Surg 1993; 80: 173-6 107-11
    • TRATADO DE PIE DIABÉTICO Kim D, Gianturco LE, Porter DH, Orron DE, Kuntz RE, Kent influence the result of femorofemoral bypass? Analysis KC, Siegel JB, Schlam BW, Skillman JJ. Peripheral direc- of 70 consecutive cases with long term follow-up. J Vasc tional atherectomy: 4-year experience. Radiology 1992; Surg. 1996; 14: 363-70. 183:773-8. Prendiville EJ, Yeager A, O`Donnell TF jr., Coleman JC, Krepel VM, Van Andel GJ, Van Erp WFM, Breslau PJ. Jaworek A, Callow AD, Mackey WC, Deterling RA. Long- Percutaneus trasluminal angioplasty of the femoropo- term results with the above-knee popliteal expanded pliteal artery: initial and long-term results. Radiology polytetrafluorethylene graft. J Vasc Surg 1990; 11:517-24. 1985; 156:325-8. Probst P, Cerny P, Owens A, Mahler F. Patency after Leather RP, Shah DM, Karmody AM. Infrapopliteal bypass femoral angioplasty: Correlation of angiographic appe- for limb salvage: Increased patency and utilization of the arance with clinical findings. Am J Roentgenol 1983; saphenous vein used in siyu. Surgery. 1981; 90: 1.000-8. 140:1227-32. Leather RP, Karmody AM, In situ saphenous vein arterial Quiñones-Baldrich WJ, Prego AA, Ucelay-Gomez R, bypass for the treatment of limb ischemia. In Manick Freischlag JA, Ahn SS, Baker JD, Machleder HI, Moore JA, ed. Advances in Surgery, vol 19. Chicago: Year Book WS. Long term result of infrainguinal revascularization Medical Publishers. 1996, pp 175- 8. with PTFE: A ten years experience. J Vasc Surg. 1992; 16: 209-17 Matsi PJ, Manninen HI, Suhonen MT, Pirinen AE, Soimakallio S. Chronic critical lower-limb ischemia: pros- Rolling DL, Towne JB, Bernhard VM: Isolated profundo- pective trial of angioplasty with 1-36 months follow- plasty for limb salvage. J Vasc Surg. 1985; 2: 585-90 up. Radiology 1993; 188:381-7. Rousseau HP, Raillat CR, Joffre FG, Knight CJ, Gimested Matsi PJ, Manninen HI, Vanninen RL, Suhonen MT, OkSala MC. Treatment of femoropopliteal stenoses by mean Y, Laakso M, Hakkarainen T, Soimakallio S. of self-expandable endoprotheses: midterm results. Femoropopliteal angioplasty in patients with claudica- Radiology 1989; 172:961-4. tion: primary and secondary in 140 limbs with 1-3-5 year Rutherford RB. Aortobifemoral bypass, the gold stan- follow-up. Radiology 1994; 191:727-33. 198 dard: Thecnical considerations. Semin Vasc Surg. 1994; Matsi PJ, Manninen HI. Impact of different patency criteria 7: 11-6 on long-term results of femoropopliteal angioplasty: Rutherford RB, Shanonn FL. Lumbar sympathectomy: indi- analysis of 106 patients with claudication. J Vasc cations and technique. EN: Vascular Surgery.Edited by Intervent Radiol 1995; 6:159-63. Rutherford RB. 4th. de. Philadelphia : W.B. Saunders Matsi PJ, Manninen HI, Söder HK, Mustonen P, Kouri J. Company, 1995: pag. 879. Percutaneus transluminal angioplasty in femoral artery Rutherford RB, Patt A, Pearce WH. Extra-anatomic bypass: occclusions: primary and long-term results in 107 clau- A closer view. J Vasc Surg. 1987; 6: 437-46. dicant patients using femoral and popliteal catheteri- zacion techniques. Clin Radiol 1995; 50:237-44. Saab MH, Smith DC, Aka PK, Brownlee RW, Killeen JD. Percutaneus Transluminal Angioplasty of tibial arteries McCollum CN, Kenchinton G, Alexander CE, Franks PJ, for limb salvage. Cardiovasc Intervent Radiol 1992; Greenhalgh RM. PTFE or HUV for femoropopliteal by- 15:211-6. pass: A multicentre trial. Eur J Vasc Surg. 1991; 5: 435- 43. Sanchez LA, Gupta SK, Veith FJ, Goldsmith J, Lyon RT, Wengerter KR, Paneta TF, Marin ML, Cynamon J, Berdejo Moore WS. Therapeutic options for femoropopliteal occlu- G, Sprayregen S, Bakal CW. A ten-year experience with sive disease. Circulation 1991; 83(suppl. I ): I-91-I-93. one hundred fifty failing or threatened vein and poly- Murray RR jr., Hewes RC, White RI jr., Mitchell SE, Auster tetrafluorethylene arterial by-pass grafts. J Vasc Surg M, Chang R, Kadir S, Kinninson ML, Kaufman SL. Long- 1991; 14:729-38. segment femoropopliteal stenosis: Is angioplasty a boon Schneider JR, McDaniel MD, Walsh DB, Zwolack RM, or a bust?. Radiology 1987; 162:473-6. Cronenwett JL. Axillofemoral bypass: Outcome and Norman PE, House AK. The early use of operative lumbar hemodynamic result in high-risk patients. J Vasc Surg. sympathectomy in peripheral vascular disease. J 1992; 15:952-63. Cardiovasc Surg 1988; 29:717-22. Scheneider JR, Golan JF. The role of extraanatomic bypass Perler BA, Williama GM: Does donor iliac artery percu- in the management of bilateral aortoiliac disease. Semin taneous transluminal angioplsty or stent placement Vasc Surg. 1994; 7: 35-44.
    • BIBLIOGRAFÍA. Shah RM, Peerr RM, Upson JF, Ricotta JJ. Donor iliac angio- safe and successful procedure. Eur J Endovasc Surg 1995; plasty and crossover femorofemoral bypass. Am J Surg. 9:341-5 1992; 164: 295-8. Veith JF, Ascer E, Gupta SK, White–Flores S, Sprayregen Simpson JB, Selmon MR, Robertson GC, Cipriano PR, S, Scher LA, Samson RH. Tibiotibial vein bypass grafts: Hayden WG, Johnson DE, Fogarty TJ. Transluminal athe- a new operation for limb salvage. J Vasc Surg. 1985; 2: rectomy for occlusive peripheral vascular disease Am J 552-7. Cardiol 1988; 61:96G-101G. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Stokes KR, Strunk HM, Campbell DR, Gibbos GW, Wheeler Scher LA, Towne JB, Bernhard VM, Boiner P, Flinn WR, HG, Clouse ME. Five-years results of iliac and femoro- popliteal Angioplasty in diabetic patients. Radiology Astelford P, Yao ST, Bergan JJ. Six year prospective multi- 1990; 174:977-82. center randomiced comparison of autologous safenous vein and expanded PTFE grafs in infrainguinal recons- Stonebridge PA, Prescott RJ, Ruckley CV. Randomized truction. J Vasc Surg. 1986; 3: 104-14. trial comparing infrainguinal polytetrafluoroethylene by-pass grafting with an d without vein interposition Veith FJ, Haimovici H. Femoropopliteal arterioescle- cuff at the distal anastomosis. J Vasc Surg. 1997; 26: rotic occlusive disease. In Haimovici H (ed): Vascular 543-50. Surgery. Principes and Techniques. 4th ed. 1996, pp Taylor LM, Phinney ES, Porter JM: Present status of 605-31 reversed vein by-pass for lower extremity revasculari- Veith FJ, Gupta SK, Wengerter KR, Goldsmith J, Rivers SP, zation. J Vasc Surg. 1986; 3: 288-97. Bakal CW, Dietzek AM, Cynamon J, Sprayregen S, Taylor LM, Edwards JM, Porter JM. Present status of Gliedman ML. Changing arterioesclerotic disease reversed vein by-pass grafting: five-years results of a patterns and management strategies in lower-limb thre- modern series. J Vasc Surg 1990; 11:193-206. atening ischemia. Ann Surg 1990; 212:402-14. Tovar-Pardo AE, Bernhard VM. Where the profunda Walker PM, Johnston KW. Predicting the success of a femoris artery fits in the spectrum of lower limb revas- sympathectomy: a retrospective study using discrimi- 199 cularitation. Semin Vasc Surg. 1995; 8: 225- 35. nant function and multiple regression analysis. Surgery Tunis SR, Bass EB, Esteinberg EP. The use of angioplasty, 1980; 87:216-21. by pass surgery and amputation in the management of periferal vascular disease. N Engl Med 1991; 325-56. Weinstein ES, Langsfeld M.Aortoiliac endarterectomy. Semin Vasc Surg. 1994; 7: 28-34 Van Andel GL, Van Erp WFM, Kreper VM, Breslau PJ. Percutaneus transluminal dilatation of the iliac artery: Wolfe JH, Tyrrell MR. Improving the patency of prost- Long-term results. Radiology 1985; 156:321-3. hetic grafts with vein cuffs. Semin Vasc Surg. 1995; 8: Van Der Stricht J. Lumbar sympathectomy in oclusive dise- 247-52. ases. Int angiol 1985; 4:345-58. Yang XM, Manninem H, Matsi P, Soimakllio S. Parcutaneus Varty K, Bolia A, Naylor AR, Bell PRF and London NJM. endovascular stenting: development, investigation and Infrapopliteal Percutaneus Transluminal Angioplasty: A application. Eur J Radiol 1991; 13:161-73.
    • TRATADO DE PIE DIABÉTICO sures. Foot Ankle, 11(3):141-270, 1990. CAPITULO IX Jeffcoate W, Macfarlane R eds. The diabetic foot. An illus- Alexander IJ. El Pie. Exploración y diagnóstico. Ed. Jims trated guide to management. London. Chapman & Hall. (1992). 1995. Baumhauer, J.F. et al.: A comparison study of plantar foot Myerson, M.S., Papa, J., Eaton, K., and Wilson, K.: The pressure in a standardized shoe, total contact cast, and total contact cast for management of neuropathic prefabricated pneumatic walking brace. Foot and plantar ulceration of the foot. J. Bone Joint Surg., 74ª: Ankle,18(1):26-33, 1997. 261-269, 1992. Boulton A.J., Bowker J.H., Gadia M. et al. Use of plaster Myerson, M., and Wilson, K.: Management of neuro- casts in the management of diabetic neuropathic foot pathic ulceration with the total contact cast. In Levin, ulceration. Diabetes care 9: 149-152, 1986 M.E., O'Neal, L.W., and Bowker, J.H. (eds.), The Diabetic Cespedes T, Dorca A. Pie Diabético. Conceptos acttuales Foot, 5th Ed. St. Louis, Mosby-Year Book, 1992, p. 145- y bases de actuación. Ed. Díaz Santos. Barcelona(1996). 152. Coleman, W.C.: The relief of pressures using outer shoe Padrós C. Protocolo de exploración del Pie Diabético. Rev. sole modifications. InMothirami Patil, K., and Srinivasa, Esp. Podología. Nov. (1996). H. (eds.), Proceedings of the International Priollet P, Letanoux M, Cormier JM.Le pied diabétic et les Coleman WC, Brand PW, Birke JA. The total contact cast: principes généraux de sa prise en charge .JMV a therapy for plantar ulceration on insensitive feet. J 1993;18:24-29 Am Podiatr Med Assoe 1984;74:548-52. Rodríguez E. Ortopodología aplicada. Experiencia. Conference on Biomechanics and Clinical Kinesiology of Ed.Podoespecial S.A.Barcelona 1990. the Hand and Foot. Madras, India: lndian Institute of Schaff, P.S., and Cavanagh, P.R.: Shoes for the insensitive Technology, 1985, pp. 29-31. foot, the effect of a "rocker bottom" shoe modifica- Duckworth,T.,Boulton,A.J.M.,Betts,R.P.,Franks, C.I., and tion of plantar pressure distribution. Foot Ankle, 200 Ward, J.D.: Plantar pressure measurements and the 113:129-140, 1990. prevention of ulceration in the diabetic foot. J.Bone Soames RW, Richardson RPS. Stride length and cadence: Joint Surg.,67B:7985, 1985. their influence on ground reactive forces during gait. Frykberg RG. Podiatric problems in diabetes. En: In: Winter DA, Norman RW, Wells RP, Hayes KC, Patla Management of Diabetic Foot Problems. GP Kozak AE, editors. Biomechanics IX-A. Champaign (IL): Human ed.Philadelphia, W.B. Saunders, 1984, pp: 45-67 Kinetics Publications; 1995. Fylling CP. Wound healing: an update. Comprehensive Viladot. Patología del antepié. Ed. Toray S.A. Barcelona wound management for prevention of amputation. (1984). Diabetes Spectrum 1992; 5:358-9. Wertsch, J.J., Frank, L.W., Zhu, H., Price, M.B., Harris, G.F., Holmes, G.B., and Timmerman, L.: A quantitative assess- and Alba, H.M.: Plantar pressures with total contact ment of the effect of metatarsal pads on plantar pres- casting. J. Rehab. Res. Dev., 32(3):205-209, 1995.
    • BIBLIOGRAFÍA. Keagy BA, Schwartz JA, Kotb M, et al. Lower extremity ampu- CAPITULO X tation: the control series. J Vasc Surg 1986; 4: 321-6. Baumgartner R: Failures in through-knee amputation. Larsson J. Lower extremity amputation in diabetic Prosthet Orthot lnt 1983 7:116-118. patients. Lund University, Doctoral Thesis, 1994. Bild DE, Selby JV, Sinnock P, et al. Lower extremity ampu- Laverly LA, van Houtum WH, Harkless LB. In-hospital tation in people with diabetes. Epidemiology and mortality and disposition od diabetic amputees in The prevention. Diabetes Care 1989; 12(1):24-31. Netherlands. Diabet Med 1996; 13: 192-197. Bradley RV. Desbridamientos y amputaciones. En Levin Lawrence A, Lavery DPM y cols. Variation in the incidence ME, O´Neal LW eds. El pie diabético. Elicien. 1977. pp and proportion od diabetes-related amputation in mino- 205-34. rities.Diabetes Care 1996; 19: 48-521- Dwars BJ, Van Den Broek TA, Ravwerda JA, Bakker FC. Lepantalo M, Isoniemi H, Kyllonen L. Can the failure of Criteria for reliable selection of the lowest level of a below-knee amputation be predicted. Ann Chir amputation in perpheral vascular disease. J Vasc Surg Gynaecol 1987; 76:119-23. 1992; 15:536-42 Malone JM, Goldstone J. Lower extremity amputation. Ebskov B, Josephson P. Incidence of reamputation and In Moore WS (ed): Vascular Surgery: A Comprehensive death after gangrene of the lower extremity. Prosthetics Review, 1st ed. New York, Grune & Stratton, 1984: 909- and Orthotics International 1980; 4 77-80. 74. Falstie-Jensen N, Christensen KS, Br*chner-Mortensen J. Moore WS. Hall AD, Lim RC. Below-the-knee amputa- Long posterior flap versus equal sagittal flaps in below- tions for ischemic gangrene. Am J Surg. 1972; 124: 127- knee amputation for ischaemia. J Bone Joint Surg 1989; 134. 71-B:102- 4. Moss SE, Klein R, Klein BE. Long-term incidence of lower- Finch DRA, MacDougal M, Tibbs DJ, Morris PJ. Amputation extremity amputations in a diabetic population. Arch for vascular disease: The experience of a peripheral Fam Med 1996; 5: 391-398 201 vascular unit. Br J Surg 1980; 67:233-7. Most RS, Sinnock P. The epidemiology of lower extremity Fylling CP, Knighton DR. Amputation in the diabetic popu- amputations in diabetic individuals. Diabetes Care 1983; lation: incidence, cuses, cost, treatment, and preven- 6:87-91. tion. J Enterostom Ther 1989; 16:247-55. Porter JM, Baur GM, Taylor LM. Lower extremity ampu- Hecher ML, Jacobs BS. Lower extremity amputations in tations for ischemia. Arch Surg 1981; 116:89-92. diabetic patients. Diabetes 1970; 19:189. Sanders LJ, Dunlap G. Transmetatarsal amputation: a Hodge MJ, Peters TG, Efird WG. Amputation of the distal successful approach to limb salvage. J Am Pod Med portion of the foot. South Med J 1989; 82:1138-42. Assoc 1992; 82:129-35.
    • TRATADO DE PIE DIABÉTICO Lyquist, E: The OHC knee-disarticulation prosthesis. Orthot CAPITULO XI Pros 1976;30:27-28, Aircast Incorporated: Pneumatic walker.Aircast lncorpo- Lyquist, E: Casting the through-knee stump. Prosthet rated, Summit,NJ,1996. Orthot lnt 1983;7:104-106. Basset AC: The development and application of pulsed Mueller MJ, Diamond J. Biomechanical treatment electromagnetic fields for united fracturs and artho- approach to diabetic plantar ulcers. Phys. Therap. 68: desis. Orthop Clin North Am 15: 63, 1984. 1917, 1988. Birke J.A., Sims D.S., Buford W.L. Walking casts: Effect on Mueller M.J., Diamond J.E., Sinacore D.R., et al. Total plantar foot pressures. J. Rehabil. Res. 22: 18-22, 1985. contact casting in treatment of diabetic plantar ukcers: Botta, P, Baumgartner, R: Socket design and manufactu- Controlled clinical trial. Diabetes care. 1989.12: 384-388, ring technique for through-knee stumps. Prosthet Mueller MJ, Allen BT, Sinacore DR. Incidence of skin Orthot lnt 7:100-103, 1983. breakdown and higher amputation after transmeta- Brodsky J.W., Kourosh S., Stills M., et al. Objective evalua- tarsal amputation: implications for rehabilitation. Arch tion of insert material for diabetic and athletic foot- Phys Med Rehabil 1995; 76:50-4. wear. Foot and ankle 1988.9: 111-116, Murray HJ, Veves A. y cols. Role of experimental socks in Caputo GM, Cavanagh PR, Ulbrecht JS, et al. Assessment the care of the high-risk diabetic foot. A multicenter and management of foot disease patients with diabetes. patient evaluation study. Diabetes Care 1993; 16: 1190- N Engl J Med 1994; 331:854-60. 1192 Falkenberg M, Apelqvist J y cols. Foot ulcers in patients Novick A, Birke JA, Graham SL, Koziatek E. Effect of a with diabetes. Preventive measures reduce the number walking splint and total contact casts on plantar torees. of amputations. Lakartidningen 1993; 90: 4221-4 J Prosthet Orthot 1995;3:168-78. Sinacore DR, Muller MJ, Diamond JE, Blair VP 3rd, Dury D, Heim, P.A., Walker, S.C., and Puliium, G.: Total contact Rose SJ. Diabetic plantar ulcers treated by total contact cast-ing in diabetic patients with neuropathic foot ulce- 202 casting. A clinical report. Phys. Ther:67:1543-9. ration.Arch.Phys.Med.Rehab.,65:691-693, 1984. Steinberg FU, Sunwoo I, Roettger RF. Prosthetic rehabi- Helm PA, Walker SC, Pullium GF. Total contact casting in litation of geriatric amputee patients: A follow-up study. diabetic patients with neuropathic foot ulcers. Arch Arch Phys Med Rehabil 1985; 66:742. Phys Med Rehabil 1990; 65:691-3. Thompson, F.M., and Coughin, M.J.: The high price of Herman WH, Teusch SM,Geiss LS. Diabetes Mellitus. En: high fashion footwear. lnstr. Course Lect., 76A(10):1586- Amler RW,Dull HB, editors. Closing the gap: the burden 1593, 1994. of unneceseary illness.Oxford: Oxford University Press,1987:72-82 Walker, S.C., Heim, P.A., and Puilium, G.: Total contact cast-ing and chronic diabetic neuropathic foot ulcera- Hughes, J., Kriss, S., and Kienegrman, L.: A clinician's view tions: healing rates by wound location. Arch. Phys. of foot pressure: a comparison of three different Med. Rehab., 68:217-221, 1987. methods of mea-surement. Foot Ankle, 7:277-284, 1987. Workshop on Knee-Disarticulation and Hip-Disarticulation Kozak GP, Campbell DR, Frykberg RG, Habershaaw GM Prostheses.Subcommittee on Design and Development. eds. Management of foot problems. 2nd de. Committee on Prosthetics Research and Development, Philadelphia, Pennsylvania. WB Saunders 1995 Division of Engineering-National Research Council, Laing W., Cogley D.I., Klenerman L. Neuropathic foot National Academy of Sciences, National Acad-emy of ulceration treated by total contact casts. J. Bone Jt. Engineering, San Francisco, Calif, 1969. Surg. 74 B: 133-136, 1992. Zhu, H., Harris, G.F., Alba, H., et al.: Effect of walking Light JT Jr, Rice JC, Kerstein MD. Sequelae of limited cadence on plantar pressures. Arch. Phys. Med. Rehab., amputation. Surgery 1988; 154:305. 72:834, 1991.
    • BIBLIOGRAFÍA. Orthop. Clinics of North Am.1989 20: 605-619,. CAPITULO XII Pinzur M, Sage R, Schwaegler P: Ray resection in the dysvas- Anderson R.B., Foster M.D., Gould J.S., et al. Free tissue cular foot-retrospective review. Clin Orthop 191:232, 1984 transfer and calcanectomy as treatment of chronic oste- omyelitis of the os calcis. Foot Ankle. 199011:168-171, Pinzur M, Kaminsky M, Sage R, et al: Amputations at the middle level of the foot. J Bone Joint Surg Am 68:1061- Baumgartner R. Stinus H. Tratamiento orto-protésico del 1064, 1986. pie. Ed. Masson. Barcelona 1997. Pinzur M, Morrison C, Sage R, et al: Syme's two-stage Brodsky, J.W.: The diabetic foot.In Mann,R.A.(ed.),Surgery amputation in insulin-requiring diabetics with gangrene of the Foot and Ankle,6th Ed.St.Louis, Mosby-Year of the forefoot. Foot Ankle 11:394-396, 1991. Book,1992,pp. 877-955. Saltzman, C.L., Johnson, K., Goidstein, R.H., and Donnelly: Fernandez Carmena L,Gamella Pizarro c. y cols. El pie The patellar tendon-bearing brace as treatment for diabético. Med. Integral 1993; 21:70-86 neu-rotrophic arthropathy: a dynamic force monitoring Gianfortune P, Pulla R, Sage R: Ray resections in the insen- study. Foot Ankle, 13(1):14-21, 1992. sitive or dysvascular foot: A critical review. J Foot Surg Sammarco GJ, Scioli MW. Examination of the foot and 24:103-107, 1985. ankle. In: Sammarco GJ, ed. The foot in diabetes. Halimi S, Benhamou PY,Charras H. Le cout du pied diabe- Philadlephia: Lea & Febiger 1991; 1:29-35. tique. Diabete-Metab 1993; 19: 518-522 Sanders LJ. Diabetes Mellitus. Prevention of amputation. Harrelson J.M. Management of the diabetic foot. The J Am Podiatr Med Assoc 1994; 84: 322-8 203
    • TRATADO DE PIE DIABÉTICO Reiber GE. Diabetic foot care: financial implications and prac- CAPITULO XIII tice guidelines. Diabetes Care 1992; 15( Suppl 1):29-31 Anderson RM, Funnell MM. Strategies for diabetes patient Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for education: a review of fundamentals. In: Alberti KGMM, amputation in patients with diabetes. Epidemiology Krall LP, eds. Diabetes Annual 7. Elsevier Science and prevention. Diabetes Care Ann Int Med. 1992; Publishers, 1993; 245-57. 117:97-102. Gibbons GW. Management of the diabetic foot. Surg Rubio JA, Alvarez J. Costes económicos de la diabetes Rounds 1986; 9 (1):55-9. mellitus: revisión crítica y valoración coste - eficacia de Gibbons GW, Marcaccio EJ, Burgess AM et al. Improved las estartegias propuestas para su reducción. Aten quality of diabetic foot care 1984 vs 1990: reduced Primaria 1998; 22: 239-255 length of stay and costs, insufficient reimbursement. Scottish Intercollegiate Guideline Network. Management Arch Surg 1993; 128 (5):576-81. of diabetic foot disease. Sign Publication nº 12 (Scotland), Goldman D, Ellis S. Centers for Disease Control and 1997. Prevention: Cooperative Agreement No. 2/CCU100351- Sieradzki J,Koblik T. y cols. Diabetic foot syndrome in 08. Providence, RI, Rhode Island Department of Health, clinical practice. Results after one year at the Diabetic 1988; 76. Foot Consulting Unit. Przegl Lek 1996; 53: 6-8 International DiabetesFederation, Triennial Report 1991- Sitonen OI, Sitonen JT, Niskanen LK, et al. Lower extre- 1994. Diabetes: a serious disease that deserves your mity amputations in diabetic and non diabetic patients. attention ...and respect. Ap. A: p.42 Diabetes Care 1993; 16:16-20. Larsson J, Apelqvist J. Towards less amputations in The Diabetes Control and Complications Trial Research diabetic,patients: incidence, causes, cost, treatment, Group. The effect of intensive treatment of Diabetes and prevention-a review. Acta Orthop Scand 1995; 66 on the development and progression of long-term (2):181-92. complications in insulin-dependent diabetes mellitus. 204 Larsson J, Apelqvist J. y cols. Decreasing incidence of N Engl J Med 1993 ; 329 : 977-986. mayor amputation in diabetic patiernts: a consequence The National Swedish Board of Health and Welfare. of a multidisciplinary foor care team approach ?.Diabet Project report on diabetes- related lower extremity Med 1995; 12: 770-776 amputation with a survey of amputations in the coun- Marvin E, Levin MD. Preventing amputaction in the ties of Kopparberg and Värmland. In Swedish. patient with diabetes. Diabetes Care 1995; 18: 1383- (Amputations-frekvens vid diabetes. Amputation pä 1394. nedre extremiteten vid diabetes med en kartläggning av amputationer i Kopparbergs och Värmlands län. Aktiv Miller AD, Van Buskirk A, Nerhoek-Oftedal W, Miller ER, Uppföljning. Projektrapport, Socialstyrelsen. Artikelnr Trenton MA. Diabetes-related lower extremity ampu- 1993-13-12). Stockholm 1993. tations in New Jersey, 1979 to 1981. J Med Soc NJ 1985; 82:723-6. WHO.Diabetes mellitus: report of a WHO study group. World Health Organ Tech Rep Ser nº 727 ,1985. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care WHO."Diabetes Mellitus Programme". Ag.1996 1990; 13: 513-521 Wooldridge J, Bergeron J, Thornton C. Preventing dabetic Plummer ES, Albert SG. Focused assessment of foot care foot disease: lesson from Medicare therapeutic shoe in older adults. J Am Geriatr Soc 1996; 44: 310.313 demostration. Am J Public Health 1996; 86: 935-938